CAR T-cell therapy is considered a milestone in personalized cancer treatment. In this approach, a patient's own immune cells ...
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice ...
Clinical Trials Arena on MSN
Protara’s cell therapy shows treatment durability in mid-stage NMIBC study
If approved, TARA-002 could become the first cell therapy to get the regulatory go-ahead in NMIBC and the first drug ...
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for ...
After a surprise rejection at the beginning of 2026, the FDA has agreed to reconsider a T-cell therapy based on the same ...
Americans Skip Overseas Travel as Stem Cell Exosome Therapy Lands at 5 U.S. Locations New York, United States - May 14, ...
HaemaLogiX has opened patient enrolment for its phase 1 Koala clinical trial at the Peter MacCallum Cancer Centre, marking ...
Standardizing cell therapy production will require a combination of AI, automation, and innovative bioprocessing technologies ...
Late-breaking oral presentation to highlight AlloNK + rituximab clinical responses comparable to autologous CAR T-cell therapy in 31 patients with rheumatologic diseases, including 71% ACR50 response ...
In this webinar, Gonçalo Regalo discusses how raw materials, media composition, and process design influence scalable cell ...
PSC-derived cells can reverse type 1 diabetes in mice and may overcome some of the hurdles faced by existing stem cell ...
Investigational dopaminergic cell replacement therapy shows safety and preliminary motor improvements in early-phase Parkinson disease clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results